Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Amsalog well tolerated at oral doses up to 1600 mg/m2 in cancer patients

March 26, 2002

Recent patent covers Agouron's CDK inhibitors

March 25, 2002

Novel GnRH antagonists for sex hormone-dependent conditions identified at GSK

March 22, 2002

Cell Genesys discontinues p27/p16 gene therapy collaboration

March 22, 2002

TAS-108, a safer antiestrogen for breast cancer

March 22, 2002

Irofulven tested in cancer patients in combination with cisplatin

March 21, 2002

Aventis discloses compounds active against telomerase

March 21, 2002

Compounds for cancer gene therapy reported by Fujisawa

March 21, 2002

Rationally designed anticancer drugs targeting key enzymes as a new approach to breast cancer

March 21, 2002

Steroid sulfatase inhibitors disclosed by Nippon Organon

March 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...